LZAGF
Lonza Group AG

38
Loading...
Loading...
Lonza Group AG engages in the supply of pharmaceutical, healthcare, and life science products. It operates through the following segments: Biologics, Small Molecules, Cell and Gene, Capsule and Health Ingredients, and Corporate. The Biologics segment serves as contract development and manufacturing partner for biopharmaceuticals, catering customers for all clinical and commercial manufacturing needs throughout the product lifecycle. The Small Molecules segment design, development, and manufacturing, with the ability to offer integrated drug substances to drug product solutions, including particle engineering and drug product packaging. The Cell and Gene segment develops, de-risk, commercializes, and scales their emerging therapies through its three business areas Cell and Gene Technologies, Bioscience, and Personalized Medicine. The Capsule and Health Ingredients segment provides innovative capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical companies. The Corporate segment refers to finance and accounting, legal, communication, information technology, and human resources functions. The company was founded on October 27, 1897 and is headquartered in Basel, Switzerland.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
18,686

Frequently Asked Questions

What is Market Cap of Lonza Group AG?
What is the 52-week high for Lonza Group AG?
What is the 52-week low for Lonza Group AG?
What is Lonza Group AG stock price today?
What was Lonza Group AG stock price yesterday?
What is the PE ratio of Lonza Group AG?
What is the Price-to-Book ratio of Lonza Group AG?
What is the 50-day moving average of Lonza Group AG?
How many employess does Lonza Group AG has?

Latest LZAGF News

View
No LZAGF news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.